Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

13.3%

2 terminated out of 15 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed with results

Key Signals

2 with results80% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (7)
P 1 (4)
P 2 (1)
P 4 (2)

Trial Status

Completed8
Recruiting4
Terminated2
Withdrawn1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (15)

Research Network

Activity Timeline